Aclarion (ACON) Competitors $7.68 -0.09 (-1.16%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ACON vs. BRTX, BGLC, SSY, DHAC, NIVF, BACK, OTRK, BTTX, UPHL, and OPGNShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), IMAC (BACK), Ontrak (OTRK), Better Therapeutics (BTTX), UpHealth (UPHL), and OpGen (OPGN). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors Biorestorative Therapies BioNexus Gene Lab SunLink Health Systems Digital Health Acquisition NewGenIvf Group IMAC Ontrak Better Therapeutics UpHealth OpGen Aclarion (NASDAQ:ACON) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts recommend ACON or BRTX? Aclarion currently has a consensus target price of $11,758.50, indicating a potential upside of 153,005.47%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Biorestorative Therapies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Biorestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, ACON or BRTX? Aclarion has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, Biorestorative Therapies has a beta of -0.43, meaning that its share price is 143% less volatile than the S&P 500. Which has higher valuation and earnings, ACON or BRTX? Aclarion has higher earnings, but lower revenue than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$50K89.09-$6.99MN/AN/ABiorestorative Therapies$605.20K19.51-$8.98M-$1.27-1.17 Is ACON or BRTX more profitable? Biorestorative Therapies has a net margin of -1,772.40% compared to Aclarion's net margin of -11,238.59%. Aclarion's return on equity of -83.63% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-11,238.59% -83.63% -76.55% Biorestorative Therapies -1,772.40%-137.00%-88.31% Do insiders and institutionals hold more shares of ACON or BRTX? 7.5% of Aclarion shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 0.8% of Aclarion shares are held by company insiders. Comparatively, 30.8% of Biorestorative Therapies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer ACON or BRTX? In the previous week, Aclarion and Aclarion both had 1 articles in the media. Biorestorative Therapies' average media sentiment score of 1.91 beat Aclarion's score of 1.89 indicating that Biorestorative Therapies is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Very Positive Biorestorative Therapies Very Positive SummaryAclarion beats Biorestorative Therapies on 7 of the 12 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACON vs. The Competition Export to ExcelMetricAclarionMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.45M$7.51B$5.70B$10.27BDividend YieldN/A2.80%5.72%4.60%P/E RatioN/A75.0375.8126.51Price / Sales89.0936.18492.95166.26Price / CashN/A24.0725.8129.90Price / Book0.157.8812.836.31Net Income-$6.99M$241.92M$3.28B$270.12M7 Day Performance8.49%0.25%0.24%2.04%1 Month Performance4.92%2.96%4.59%6.25%1 Year Performance-99.54%2.40%68.69%25.50% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONAclarion2.5887 of 5 stars$7.68-1.2%$11,758.50+153,005.5%-99.5%$4.45M$50K0.007Positive NewsBRTXBiorestorative Therapies2.3849 of 5 stars$1.61+0.6%N/A-10.7%$12.77M$400K-1.277Positive NewsBGLCBioNexus Gene Lab0.6208 of 5 stars$4.97-1.4%N/A+25.5%$9.05M$9.51M0.0030SSYSunLink Health SystemsN/A$1.12+16.6%N/A+43.5%$7.88M$31.09M4.661,376Gap UpDHACDigital Health AcquisitionN/A$0.67+0.0%N/A-56.4%$2.42MN/A0.002,021NIVFNewGenIvf GroupN/A$1.83flatN/A-99.7%$1.58M$5.43M0.00N/ABACKIMACN/A$0.07flatN/A-94.0%$149K$72.05K0.00180Negative NewsGap UpOTRKOntrak2.9586 of 5 stars$0.02-50.0%$3.00+14,900.0%-98.9%$84K$10.18M0.00250Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750High Trading VolumeOPGNOpGenN/A$0.00flatN/A-100.0%$1K$2.67M0.00100Positive News Related Companies and Tools Related Companies Biorestorative Therapies Competitors BioNexus Gene Lab Competitors SunLink Health Systems Competitors Digital Health Acquisition Competitors NewGenIvf Group Competitors IMAC Competitors Ontrak Competitors Better Therapeutics Competitors UpHealth Competitors OpGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACON) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACON Stock Alerts